The present article is a case study of a Polish biopharmaceutical
company, “Pure Biologics”. The company was founded in 2010 by a group of
scientists and, over the last nine years, grew substantially from just a few
individuals to nearly one hundred professionals. Initially, a privately-funded civil
partnership, Pure Biologics, has been transformed into a publicly-traded company.
Such a transformation has been possible not only because of the expertise and
growing experience of corporate management, but also the specific economic
environment and substantial public funding dedicated to innovative Small and
Medium Enterprises (SMEs).